Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | American Oncology Network: American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada | 1 | GlobeNewswire (USA) | ||
Mo | American Oncology Network, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
04.04. | Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery | 1 | GlobeNewswire (USA) | ||
03.04. | American Oncology Network Expands to Hawaii, Welcomes New Practice to Network | 1 | GlobeNewswire (USA) | ||
28.03. | American Oncology Network, Inc. - 8-K, Current Report | - | SEC Filings | ||
28.03. | American Oncology Network GAAP EPS of -$0.76, revenue of $324.2M | 1 | Seeking Alpha | ||
28.03. | American Oncology Network, Inc. ("AON") Announces Fourth Quarter and Full Year 2023 Financial Results | 65 | GlobeNewswire (Europe) | Fiscal Year 2023 Revenue was $1,279.2 million, an 11.3% increase over 2022 Patient encounter growth of 7.9% as compared to the prior fiscal year Fourth Quarter 2023 Revenue was $324.2 million, a 7.9%... ► Artikel lesen | |
26.02. | American Oncology Network to Present at Cowen Annual Health Care Conference | 1 | GlobeNewswire (USA) | ||
06.02. | American Oncology Network: Cancer and Blood Specialists of Georgia Opens New Oncology Clinic in Cumming | - | GlobeNewswire (USA) | ||
11.01. | Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting | 371 | GlobeNewswire (Europe) | FLORHAM PARK, N.J., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization... ► Artikel lesen | |
21.12.23 | Physicians from American Oncology Network Selected to Present at the American Society of Hematology Annual Meeting and Exposition | 1 | GlobeNewswire (USA) | ||
27.11.23 | American Oncology Network, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
27.11.23 | American Oncology Network, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
18.11.23 | American Oncology Network, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
14.11.23 | American Oncology Network, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
14.11.23 | American Oncology Network reports Q3 results | 1 | Seeking Alpha | ||
14.11.23 | American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results | 231 | GlobeNewswire (Europe) | Third Quarter 2023 Highlights Revenue of $336.3 million increased by 13.1% compared to the prior year quarter.Successfully transitioned to a publicly traded company with the completion of our business... ► Artikel lesen | |
14.11.23 | American Oncology Network, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
07.11.23 | American Oncology Network's Specialty Pharmacy Reports Zero Drug Waste After Value-Based Trial, Secures Unchanged Reimbursement Rate for 2024 | 1 | GlobeNewswire (USA) | ||
02.11.23 | American Oncology Network Launches New Cancer Foundation | 1 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 52,94 | +1,22 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
FRESENIUS | 27,210 | +0,11 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,420 | -0,98 % | AKTIEN IM FOKUS: Positiver Trend von FMC und Fresenius hält an | FRANKFURT (dpa-AFX) - Für die Papiere von Fresenius Medical Care (FMC) und Fresenius setzt sich der jüngste Aufwärtstrend am Montag fort. Die Titel des Medizinkonzerns und Krankenhausbetreibers Fresenius... ► Artikel lesen | |
CARL ZEISS MEDITEC | 100,30 | +1,31 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 51,83 | -0,86 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
GERRESHEIMER | 100,50 | +1,31 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
MOBILE-HEALTH NETWORK SOLUTIONS | 23,890 | +0,46 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
NEWGENIVF GROUP | 1,780 | +36,92 % | Pre-market Movers: Tevogen Bio, Freight Technologies, NewGenIvf Group, Snap, U.S. Silica | MOUNTAIN VIEW (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET).In the Green Tevogen Bio Holdings Inc. (TVGN) is up over... ► Artikel lesen | |
ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
ADAPTHEALTH | 9,960 | +3,97 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 10,580 | +1,63 % | BrightSpring Health Services appoints Timothy Wick to its board of directors | ||
LIFEMD | 11,950 | +10,44 % | LifeMD, Inc.: LifeMD to Report First Quarter 2024 Financial Results on May 8 | ||
ECKERT & ZIEGLER | 36,720 | +1,89 % | Eckert & Ziegler gutes Q1 - reicht zumindest für Prognosebestätigung. Und Kursfeuerwerk. Eintagsfliege? | Eckert & Ziegler (ISIN: DE0005659700) - Anfang Januar noch beim Platow Brief als klarer KAUF eingestuft - liefert heute im Rahmen einer ad-hoc-Meldung einen vorläufigen Blick auf die Q1-Zahlen, die... ► Artikel lesen | |
GOODRX | 7,190 | +1,55 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen |